Yes, as you state there had been chunk 500k and 1mln (x 2) buys since results with the expectation of further news and developments in Q4 with a presentation next week
Or pursue deals in Grest China region as highlighted in the July 2023 RNS below
modification to the agreement allows ValiRx to explore additional partners in a defined geographic region while TheoremRx continue their process. Recent evidence suggests that China is increasing investment in innovative pharmaceutical development and may offer additional routes for commercialisation."
Maybe there's chance of redemption for you as you've sunned your own posting up well here
"They only go on the personal attack and try and discredit posters as a way to distract when they can’t counter or make any logical reply to points raised."